Key result
Combined perioperative beta-blockade and COX-2 inhibition is proposed to improve long-term cancer outcomes.
Key points are not available for this paper at this time.
Does not support routine perioperative β/COX-2 blockade in cancer; leaves open efficacy pending randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ricon‐Becker et al. (2016) studied this question. Combined perioperative blockade of β-adrenoceptors and COX-2 is proposed as a therapeutic strategy to improve long-term cancer outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: